In Vivo Pharmacology
Murine models: breeding, genotyping, dosing (IP, retro-orbital), tissue and blood collection, glucose monitoring, live imaging. Colony management with strict protocol adherence and sample tracking.
Human insulin · PDB 3I40
Designing murine models, reading immune systems at 18 colors of resolution, and turning preclinical data into decisions in early-stage therapeutic development.
Translational research scientist with cross-sector experience across academia, government, and industry, supporting preclinical drug discovery and in vivo pharmacology in immunology, structural biology, diabetes, ophthalmology, and metabolic disease.
I design and execute in vivo studies β murine transplant and knockout models β and read out pharmacodynamic responses, biomarker profiles, and disease-relevant immune activity using multi-parameter flow cytometry and immunofluorescence-based tissue immunophenotyping. My work sits at the interface where messy biological data becomes an actionable decision: continue, redesign, or kill.
Murine models: breeding, genotyping, dosing (IP, retro-orbital), tissue and blood collection, glucose monitoring, live imaging. Colony management with strict protocol adherence and sample tracking.
Multi-parameter flow cytometry, β₯18-color panels. Cytek Aurora, BD Fortessa, Canto II. Immune subset definition and inflammatory profiling for biomarker assessment. FlowJo.
Western blotting, SDS-PAGE, ELISA, chemiluminescence detection, reverse-phase HPLC. RNA/DNA extraction, cDNA synthesis, PCR and qPCR for gene-expression and pathway analysis.
Immunofluorescence and immunohistochemistry on wholemount cornea, conjunctiva, and lacrimal gland. Microscopy and quantitative image-based immune infiltration analysis.
Preclinical safety and efficacy of ophthalmic formulations on ex vivo human organs β Franz diffusion method and BCOP, plus angiogenesis observation by HET-CAM assay.
GraphPad Prism, FlowJo, Qubit, NanoDrop, INSTRON. Mammalian and primary cell culture (adherent and suspension), phage culture with radio-isotope labeling, cell migration assays.
1D and 2D NMR spectroscopy (TOCSY, NOESY, HSQC) with signal assignment in CARA and 3D structure calculation in CYANA; UCSF Chimera. Solid-phase peptide synthesis, macrocyclization, reverse-phase HPLC.
cGLP and cGMP operations β SOPs for QC/QA, ISO and regulatory compliance, verification and validation, product labeling, and scale-up from raw material dispensing to finished product.
Alfuraih S., Patel D., Choi W., Ramasamy K., Ansari R., Sharma A. A protocol for immunostaining of macrophages in wholemount mouse cornea, conjunctiva, and lacrimal gland.
Choi W. Analyzing Functional Interactions of Designed Peptides by NMR Spectroscopy. Chapman University. doi.org/10.36837/chapman.000507 β
Lohan S., Mandal D., Choi W., et al. Small amphiphilic peptides: activity against a broad range of drug-resistant bacteria and structural insight into membranolytic properties.
Irradiation conditioning regimen increases conjunctival chemokines and impacts conjunctival macrophages: implications for ocular GVHD.
Diabetes mellitus causes neutrophil and macrophage influx to the ocular surface and lacrimal gland.
β Travel Grant Awarded Β· Hot Topic 2024Recombinant extracellular domain Klotho-Ξ± attenuates senescence in human corneal epithelial cells.
Ocular surface safety and tolerability evaluation of MG53 protein-containing hydrogel.
Open to roles in preclinical drug discovery, in vivo pharmacology, and translational immunology.